Nom du produit:6-(2-Bromoethyl)-1,3-dimethyl-5-(p-tolyl)-1H-pyrrolo[3,4-d]pyrimidine-2,4(3H,6H)-dione

IUPAC Name:6-(2-bromoethyl)-1,3-dimethyl-5-(4-methylphenyl)-1H,2H,3H,4H,6H-pyrrolo[3,4-d]pyrimidine-2,4-dione

CAS:587009-76-5
Formule moléculaire:C17H18BrN3O2
Pureté:97%
Numéro de catalogue:CM271727
Poids moléculaire:376.25

Unité d'emballage Stock disponible Prix($) Quantité
CM271727-1g in stock ȖƛǑ
CM271727-5g 1-2 Weeks ȯƥȯ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:587009-76-5
Formule moléculaire:C17H18BrN3O2
Point de fusion:-
Code SMILES:O=C1N(C)C2=CN(CCBr)C(C3=CC=C(C)C=C3)=C2C(N1C)=O
Densité:
Numéro de catalogue:CM271727
Poids moléculaire:376.25
Point d'ébullition:
N° Mdl:MFCD04032398
Stockage:

Category Infos

Pyrrolopyrimidines
Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.